EP3325451 - FUSED IMIDAZOLES AS MIDH1 INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.07.2020 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 07.06.2019 | ||
Former | Grant of patent is intended Status updated on 05.02.2019 | ||
Former | Request for examination was made Status updated on 27.04.2018 | ||
Former | The international publication has been made Status updated on 27.01.2017 | Most recent event Tooltip | 08.07.2022 | Lapse of the patent in a contracting state New state(s): MK | published on 10.08.2022 [2022/32] | Applicant(s) | For all designated states Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Im Neuenheimer Feld 280 69120 Heidelberg / DE | [2020/16] |
Former [2018/22] | For all designated states Bayer Pharma Aktiengesellschaft Müllerstrasse 178 13353 Berlin / DE | Inventor(s) | 01 /
PANKNIN, Olaf Parkstrasse 36 13187 Berlin / DE | 02 /
HARTUNG, Ingo Schillerstrasse 80 13158 Berlin / DE | 03 /
REHWINKEL, Hartmut Blücherstrasse 13 10961 Berlin / DE | 04 /
NGUYEN, Duy Heinrich-Heine-Strasse 27 10179 Berlin / DE | 05 /
ZORN, Ludwig Osianderweg 45a 13509 Berlin / DE | 06 /
HELFRICH, Petra Im Wolfsgarten 17 14612 Falkensee / DE | 07 /
ZIMMERMANN, Katja Bockumer Strasse 370 40489 Düsseldorf / DE | 08 /
NEUHAUS, Roland Lauenburger Strasse 28 12157 Berlin / DE | [2018/22] | Representative(s) | Schüssler, Andrea, et al Kanzlei Huber & Schüssler Truderinger Strasse 246 81825 München / DE | [N/P] |
Former [2018/22] | BIP Patents c/o Bayer Intellectual Property GmbH Alfred-Nobel-Straße 10 40789 Monheim am Rhein / DE | Application number, filing date | 16757565.3 | 14.07.2016 | [2018/22] | WO2016EP66720 | Priority number, date | EP20150177743 | 21.07.2015 Original published format: EP 15177743 | [2018/22] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2017012967 | Date: | 26.01.2017 | Language: | EN | [2017/04] | Type: | A1 Application with search report | No.: | EP3325451 | Date: | 30.05.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 26.01.2017 takes the place of the publication of the European patent application. | [2018/22] | Type: | B1 Patent specification | No.: | EP3325451 | Date: | 10.07.2019 | Language: | EN | [2019/28] | Search report(s) | International search report - published on: | EP | 26.01.2017 | Classification | IPC: | C07D235/30, C07D471/04, A61P35/00, A61K31/437, A61K31/4184 | [2018/22] | CPC: |
C07D235/30 (EP,US);
A61K31/4184 (EP,US);
A61K31/437 (EP,US);
A61K45/06 (US);
A61P35/00 (EP,US);
C07D471/04 (EP,US);
C12P17/10 (US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/22] | Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | KONDENSIERTE IMIDAZOLE ALS MIDH1-INHIBITOREN | [2018/22] | English: | FUSED IMIDAZOLES AS MIDH1 INHIBITORS | [2018/22] | French: | IMIDAZOLES CONDENSÉS COMME INHIBITEURS MIDH1 | [2019/07] |
Former [2018/22] | IMIDAZOLES FUSIONNÉS UTILISÉS EN TANT QU'INHIBITEURS DE MIDH1 | Entry into regional phase | 21.02.2018 | National basic fee paid | 21.02.2018 | Designation fee(s) paid | 21.02.2018 | Examination fee paid | Examination procedure | 12.01.2018 | Date on which the examining division has become responsible | 21.02.2018 | Examination requested [2018/22] | 11.09.2018 | Amendment by applicant (claims and/or description) | 06.02.2019 | Communication of intention to grant the patent | 29.05.2019 | Fee for grant paid | 29.05.2019 | Fee for publishing/printing paid | 29.05.2019 | Receipt of the translation of the claim(s) | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/33] | Fees paid | Renewal fee | 11.07.2018 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 14.07.2016 | AL | 10.07.2019 | AT | 10.07.2019 | CY | 10.07.2019 | CZ | 10.07.2019 | DK | 10.07.2019 | EE | 10.07.2019 | ES | 10.07.2019 | FI | 10.07.2019 | HR | 10.07.2019 | IT | 10.07.2019 | LT | 10.07.2019 | LV | 10.07.2019 | MC | 10.07.2019 | MK | 10.07.2019 | MT | 10.07.2019 | NL | 10.07.2019 | PL | 10.07.2019 | RO | 10.07.2019 | RS | 10.07.2019 | SE | 10.07.2019 | SI | 10.07.2019 | SK | 10.07.2019 | SM | 10.07.2019 | TR | 10.07.2019 | IE | 14.07.2019 | LU | 14.07.2019 | BE | 31.07.2019 | CH | 31.07.2019 | LI | 31.07.2019 | BG | 10.10.2019 | NO | 10.10.2019 | GR | 11.10.2019 | IS | 10.11.2019 | PT | 11.11.2019 | [2022/32] |
Former [2021/34] | HU | 14.07.2016 | |
AL | 10.07.2019 | ||
AT | 10.07.2019 | ||
CY | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
MT | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
IE | 14.07.2019 | ||
LU | 14.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2021/33] | HU | 14.07.2016 | |
AL | 10.07.2019 | ||
AT | 10.07.2019 | ||
CY | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
IE | 14.07.2019 | ||
LU | 14.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2021/26] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CY | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
IE | 14.07.2019 | ||
LU | 14.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/37] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
SI | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
IE | 14.07.2019 | ||
LU | 14.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/36] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
IE | 14.07.2019 | ||
LU | 14.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/27] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
SK | 10.07.2019 | ||
SM | 10.07.2019 | ||
TR | 10.07.2019 | ||
LU | 14.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/25] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
CZ | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
SK | 10.07.2019 | ||
TR | 10.07.2019 | ||
LU | 14.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/24] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
MC | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
TR | 10.07.2019 | ||
BE | 31.07.2019 | ||
CH | 31.07.2019 | ||
LI | 31.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
IS | 24.02.2020 | ||
Former [2020/23] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
IT | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
NL | 10.07.2019 | ||
PL | 10.07.2019 | ||
RO | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/22] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
DK | 10.07.2019 | ||
EE | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
NL | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/17] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
NL | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
TR | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/15] | AL | 10.07.2019 | |
AT | 10.07.2019 | ||
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
NL | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/12] | AT | 10.07.2019 | |
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
NL | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
IS | 10.11.2019 | ||
PT | 11.11.2019 | ||
Former [2020/11] | AT | 10.07.2019 | |
ES | 10.07.2019 | ||
FI | 10.07.2019 | ||
HR | 10.07.2019 | ||
LT | 10.07.2019 | ||
LV | 10.07.2019 | ||
NL | 10.07.2019 | ||
RS | 10.07.2019 | ||
SE | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
GR | 11.10.2019 | ||
PT | 11.11.2019 | ||
Former [2020/10] | AT | 10.07.2019 | |
FI | 10.07.2019 | ||
LT | 10.07.2019 | ||
NL | 10.07.2019 | ||
SE | 10.07.2019 | ||
BG | 10.10.2019 | ||
NO | 10.10.2019 | ||
PT | 11.11.2019 | ||
Former [2020/09] | FI | 10.07.2019 | |
LT | 10.07.2019 | ||
NL | 10.07.2019 | ||
NO | 10.10.2019 | ||
Former [2020/08] | LT | 10.07.2019 | |
NL | 10.07.2019 | ||
NO | 10.10.2019 | ||
Former [2020/07] | NL | 10.07.2019 | Cited in | International search | [AD]WO2004085425 (AMGEN INC [US]) [AD] 1-23 * page 1, paragraph 1; claims 1,50-57 *; | [AD]WO2008153701 (SCHERING CORP [US], et al) [AD] 1-23 * compounds of the examples; page 1, paragraph 1; claims 1, 121-127 *; | [A]WO2010105243 (AGIOS PHARMACEUTICALS INC [US], et al) [A] 1-23 * compounds on page 156-175; page 1; claims 1,14 *; | [A]WO2012171506 (AGIOS PHARMACEUTICALS INC [US], et al) [A] 1-23* pages 1,2; claims 1,30-35 * |